Increased expression of HOXB9 has been linked to unfavorable survival outcomes in multiple types of cancer, such as adrenocortical carcinoma [16], lung adenocarcinomas [14, 17, 18], and breast cancer [19, 20]. The gene discussed is HOXB9; the disease is adrenal cortex carcinoma.